Related Experiment Videos
Paravertebral somatic nerve block compared with peripheral nerve blocks for outpatient inguinal herniorrhaphy
Stephen M Klein1, Ricardo Pietrobon, Karen C Nielsen
1Department of Anesthesiology, Duke University Medical Center, Durham, North Carolina 27710, USA. klein006@mc.duke.edu
Regional Anesthesia and Pain Medicine
|October 10, 2002
Summary
Paravertebral somatic nerve blocks (PVB) offer effective postoperative pain management for inguinal herniorrhaphy, comparable to peripheral nerve blocks but with fewer side effects. This approach reduces opioid use and antiemetic needs, improving patient recovery.
Area of Science:
- Anesthesiology
- Surgical Pain Management
- Regional Anesthesia
Background:
- Postoperative pain and anesthetic side effects are common issues following inguinal herniorrhaphy (IH).
- Paravertebral somatic nerve blocks (PVB) present a potential solution for unilateral abdominal wall anesthesia and sustained pain relief with minimal adverse effects.
Purpose of the Study:
- To compare the efficacy and safety of paravertebral somatic nerve blocks (PVB) versus peripheral nerve blocks (PB) for managing pain after outpatient inguinal herniorrhaphy.
Main Methods:
- A prospective, single-blind study involving 46 patients undergoing IH.
- Patients received either a preoperative PVB (T10-L2) or an intraoperative PB, both using 0.5% ropivacaine.
- Opioid consumption, pain scores, and side effects were monitored for 72 hours post-procedure.
Main Results:
- The PVB group used significantly less intraoperative opioids (162 vs. 210 mg, P=.02) and required fewer opioids in the PACU (39% vs. 61%, P=.002).
- Fewer PVB patients needed antiemetic treatment (21% vs. 50%, P<.001).
- Time to first pain and overall oxycodone use were similar between groups, though 29% of PVB patients used no opioids compared to 18% in the PB group.
Conclusions:
- Paravertebral somatic nerve blocks provide analgesia comparable to peripheral nerve blocks for inguinal herniorrhaphy.
- PVB represents a viable alternative for postoperative pain management, potentially associated with reduced side effects.